Evidence map›Paper›PMID 38999241›Full record

ReviewJournal of clinical medicine2024

Proposed Clinical Algorithm for Pleuroparenchymal Fibroelastosis (PPFE).

Hideaki Yamakawa, Tsuneyuki Oda, Keishi Sugino, Takashi Hirama, Masamichi Komatsu, Takuma Katano, Taiki Fukuda, Tamiko Takemura, Yoshiaki Kubota, Tomoo Kishaba and 3 more

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Hideaki YamakawaDepartment of Respiratory Medicine, Saitama Red Cross Hospital, Saitama 330-8553, Japan.ORCID 0000-0003-2480-6087
Tsuneyuki OdaDepartment of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama 236-0051, Japan.
Keishi SuginoDepartment of Respiratory Medicine, Tsuboi Hospital, Fukushima 963-0197, Japan.
Takashi HiramaDepartment of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan.ORCID 0000-0002-9390-5057
Masamichi KomatsuFirst Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.ORCID 0000-0002-1228-1490
Takuma KatanoDepartment of Respiratory Medicine and Allergology, Aichi Medical University, Nagakute 480-1195, Japan.ORCID 0000-0003-1321-3497
Taiki FukudaDepartment of Radiology, The Jikei University School of Medicine, Tokyo 105-8461, Japan.ORCID 0000-0001-9173-738X
Tamiko TakemuraDepartment of Pathology, Kanagawa Cardiovascular and Respiratory Center, Yokohama 236-0051, Japan.
Yoshiaki KubotaDepartment of Cardiovascular Medicine, Nippon Medical School, Tokyo 113-0022, Japan.
Tomoo KishabaDepartment of Respiratory Medicine, Okinawa Chubu Hospital, Okinawa 904-2293, Japan.ORCID 0000-0003-3335-5409
Yasuhiro NorisueDepartment of Emergency and Critical Care Medicine, Tokyo Bay Urayasu Ichikawa Medical Center, Chiba 279-0001, Japan.
Jun ArayaDepartment of Respiratory Medicine, Tokyo Jikei University Hospital, Tokyo 105-8461, Japan.
Takashi OguraDepartment of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama 236-0051, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pleuroparenchymal fibroelastosis (PPFE) is characterized by fibrosis involving the pleura and subpleural lung parenchyma, predominantly in the upper lobes. As PPFE appears to occur in patients with heterogeneous etiologies, the disease course is thus also heterogenous, with some patients showing rapid progression while others have slow progression. Therefore, it is very difficult to predict prognosis with PPFE. Needless to say, this problematic matter has influenced the treatment strategy of PPFE patients. In fact, until now no evidence has been shown for use in creating an appropriate management algorithm for PPFE. We speculate that "uncoordinated breathing" is the most important reason for dyspnea in PPFE patients. Because monitoring of physique and not just pulmonary function and radiological evaluation is also very important, particularly in PPFE patients, this review focused on the characteristics of PPFE through an overview of previous studies in this field, and we proposed an algorithm as precision medicine based on the current evidence. Multiple views by the pulmonologist are needed to standardize a clinical algorithm that is necessary to correctly assess PPFE patients under the premise of maintenance of physique by providing appropriate nutritional care and pulmonary rehabilitation.

Indexed as

clinical algorithminterstitial lung diseasepleuroparenchymal fibroelastosis

Identifiers

PMID38999241
PMCPMC11242275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.